CVC Capital Partners

Latest news and articles about CVC Capital Partners from NEX English

CVC seeks investors to support Recordati acquisition deal

CVC Capital Partners is looking to gather investors to help finance its proposed acquisition of the Italian pharmaceutical company Recordati, valued at approximately <strong>€10.9 billion</strong> (around <strong>$12.7 billion</strong>). This move aims to enhance the company's competitive edge in the global pharmaceutical market.

Explore potential divestment options for Recourati after acquisition

CVC Capital Partners plans to explore potential divestment options for the Italian pharmaceutical company Recourati following its successful acquisition for €10.9 billion. This move is part of CVC's strategy to enhance its investment portfolio.